April 2011

Baxter International Inc. Acquires Prism Pharmaceuticals

United States - Illinois | United States - Pennsylvania

Baxter International Inc. acquired Prism Pharmaceuticals for $338 million, with Faegre Baker Daniels corporate partner Roger Rhoten advising.

Pennsylvania-based Prism Pharmaceuticals is a specialty pharmaceutical company which recently received FDA approval of an antiarrhythmic drug, enhancing Baxter's portfolio of acute care premix drugs.

Faegre Baker Daniels 网站使用 Cookie 来提升您的浏览体验。